Gross Profit (TTM) Chart

View Gross Profit (TTM) for EVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
Date Value
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 -0.0291M
June 30, 2021 -0.0291M
March 31, 2021 -0.0291M
December 31, 2020 -0.0291M
September 30, 2020 -0.0302M
June 30, 2020 -0.0302M
March 31, 2020 -0.0302M
December 31, 2019 -0.0302M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Autolus Therapeutics Plc 15.09M
Cellectis SA 37.38M
DBV Technologies SA -12.78M
Ascendis Pharma A/S 1.097B
Akari Therapeutics Plc 0.00